Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature - Wikidata - awgldk - TriplyDB

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature

http://www.wikidata.org/entity/Q31147797

about

An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia.Developmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia.Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia.Sex-Specific Patterns of Aberrant Brain Function in First-Episode Treatment-Naive Patients with Schizophrenia.Comparison of the peak-to-trough fluctuation in plasma concentration of long-acting injectable antipsychotics and their oral equivalents Establishing test-retest reliability of an adapted [(18)F]fallypride imaging protocol in older people.Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions.The use of PET imaging in studying cognition, genetics and pharmacotherapeutic interventions in schizophrenia.How have developments in molecular imaging techniques furthered schizophrenia research?Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment.Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer's disease.Antipsychotic Drugs and Risk of Hip Fracture in People Aged 60 and Older in Norway.Network-assisted investigation of antipsychotic drugs and their targets.Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography.Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof.In vivo quantification of striatal dopamine D2 receptor occupancy by JNJ-37822681 using [11C]raclopride and positron emission tomography.

P2860

Q27491346-41CE4B5B-1228-4B56-A670-ED1C649DE6F0 Q30386608-C4F51660-8907-4287-9610-C88C6F2F8172 Q30445688-AB113D1F-5CCD-4EA9-B94F-9A4415A980F6 Q30469285-F12444C0-4685-4A2A-BB27-303F5B6998F7 Q33635632-E639032C-103B-4A41-A812-40817FE286A1 Q33821967-A7FFF3BF-C06C-4FAD-B1C3-4093E4429C90 Q34274859-8AC07000-E2D2-4619-A694-821C19BB6F74 Q35096515-D31F0573-A478-488E-A7E9-1AA66EF34CFA Q35215692-65F91D42-8E96-4BA9-90E8-7685FBCAEE19 Q35902608-66725B3C-751A-45B9-BD66-A80DB816F2E4 Q36235106-BADFB367-9150-4777-83CF-3DE5D95B2C2E Q36994341-DA09DAEE-8185-4F44-AFAC-CADF1503C92E Q37164018-5D9CEDCA-5C12-4BC5-B857-9636AC235FDA Q37820985-996A3A9F-DA25-456E-AB16-3C313506A4E3 Q37829639-7EE94444-9BDA-4E7F-89D3-9EE19F70BC5C Q37862242-9A86287F-2072-48E8-95EF-F76C092C7D63 Q38740848-58535669-AE43-413B-9FEF-FE73EEEB5989 Q39671348-DC124831-660E-4C32-BC30-652AF2A69C8C Q43836810-7E69042D-7E28-4A0E-98AC-136BD3C22DED Q44660446-1AEF7A38-FCCF-4A36-82FB-DB1F65A8A7DA Q48155104-DE1CCFC5-541D-4E42-A7E1-92AD6D3051F5 Q48683589-766DEB4A-128D-4EAE-A584-F489E89F0965

P2860

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature

http://www.wikidata.org/entity/Q31147797

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cortical dopamine D2/D3 recept ...... vo receptor imaging literature

@ast

Cortical dopamine D2/D3 recept ...... vo receptor imaging literature

@en

type

label

Cortical dopamine D2/D3 recept ...... vo receptor imaging literature

@ast

Cortical dopamine D2/D3 recept ...... vo receptor imaging literature

@en

prefLabel

Cortical dopamine D2/D3 recept ...... vo receptor imaging literature

@ast

Cortical dopamine D2/D3 recept ...... vo receptor imaging literature

@en

P1433

Q31147797-02C4060A-3B4F-45BF-A139-7B8669808CC0

P1476

Q31147797-E86D49F9-FBD8-4D05-A334-E774274DAE59

P2093

Q31147797-04E469D1-CD2A-483C-A0B5-16466DB49E99

Q31147797-7E7B51CB-7698-433D-B1C9-C59CA02DB2CA

Q31147797-E9C9376A-995B-493E-A7E4-FAC907777B85

P2860

Q31147797-05534EDC-0B9B-462D-9215-FE776AE7B01D

Q31147797-12E2FB40-A24E-442F-82C8-9F6BDAAA52C3

Q31147797-15A721E2-6A9F-4937-AACA-918FC6DC26E6

Q31147797-191969B8-0857-47A4-90A8-7FDAF98AC0EF

Q31147797-1FD9AEFA-D490-4912-86D6-560E170F4E5E

Q31147797-221FDBFE-E56E-4AE7-A6E9-0DDB82312741

Q31147797-291E75A7-BB4C-4B5F-A970-09722C1FB46B

Q31147797-2C191420-9EDA-4B81-8571-9C44CB2A2D90

Q31147797-2D0AB103-DC65-4E6C-BEB0-06ECA8D2DE6E

Q31147797-2DC81416-F1AD-43D8-97CB-888DCD4888E0

P304

Q31147797-84399739-9E8D-40D8-BA29-DDFF4C034E76

P31

Q31147797-3a47939c-1351-47ba-b57f-2fd933d8301d

Q31147797-BB466460-F59B-4F3A-BEC7-E0AFB28C3A53

P356

Q31147797-C69481BB-5AB5-4346-8761-0F00646B6A50

P407

Q31147797-97AB8A93-7E74-431E-A064-605AB05F1122

P433

Q31147797-BF530D6C-827B-4538-B881-1C9066E0CB52

P478

Q31147797-4C1F5050-100D-4850-8A48-90B80342C82A

P50

Q31147797-321A6D5E-717B-45D4-B740-B435ABCEE9CC

P577

Q31147797-24AA3C33-AADB-4D38-9D9A-D937974A7648

P5875

Q31147797-BE4C3561-ECEC-49A2-A6B1-C5D13F6CA673

P698

Q31147797-D519D751-C736-4553-9C02-34BE24DCF0B1

P921

Q31147797-75bb0fb3-dd9e-420e-a0b4-d46934699acc

P932

Q31147797-EFCEB8EF-6F90-4AB0-955D-F26B5ED68314

P356

P1433

Schizophrenia Bulletin

P1476

Cortical dopamine D2/D3 recept ...... vo receptor imaging literature

@en

P2093

John M Davis

http://www.w3.org/2001/XMLSchema#string

Lyn S Pilowsky

http://www.w3.org/2001/XMLSchema#string

Stefan Leucht

http://www.w3.org/2001/XMLSchema#string

P2860

MRI anatomy of schizophrenia.

Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects.

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data.

Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies.

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study.

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.

Hippocampal neurons in schizophrenia.

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

Risperidone in the treatment of schizophrenia.

P304

789-797

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/SCHBUL/SBN009

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-02-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5549546

http://www.w3.org/2001/XMLSchema#string

P698

18303092

http://www.w3.org/2001/XMLSchema#string

P921

P932

2696370

http://www.w3.org/2001/XMLSchema#string